Cargando…

Assessment of pulmonary surfactant in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Schousboe, Peter, Wiese, Lothar, Heiring, Christian, Verder, Henrik, Poorisrisak, Porntiva, Verder, Povl, Nielsen, Henning Bay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475719/ https://www.ncbi.nlm.nih.gov/pubmed/32894160 http://dx.doi.org/10.1186/s13054-020-03268-9

Ejemplares similares

Reduced levels of pulmonary surfactant in COVID-19 ARDS
por: Schousboe, Peter, et al.
Publicado: (2022)

Bronchopulmonary dysplasia predicted at birth by artificial intelligence
por: Verder, Henrik, et al.
Publicado: (2020)

Predicting respiratory distress syndrome at birth using a fast test based on spectroscopy of gastric aspirates: 2. Clinical part
por: Heiring, Christian, et al.
Publicado: (2019)

Fatal case of hospital-acquired hypernatraemia in a neonate: lessons learned from a tragic error
por: Overgaard-Steensen, Christian, et al.
Publicado: (2020)

Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants
por: Chawes, Bo L.K., et al.
Publicado: (2012)

Rapid test for lung maturity, based on spectroscopy of gastric aspirate, predicted respiratory distress syndrome with high sensitivity
por: Verder, Henrik, et al.
Publicado: (2016)

Danish premature birth rates during the COVID-19 lockdown
por: Hedermann, Gitte, et al.
Publicado: (2021)

Pulmonary surfactant and COVID-19: A new synthesis
por: Ninham, Barry, et al.
Publicado: (2022)

Surfactant protein A mediates pulmonary clearance of Staphylococcus aureus
por: Veith, Nils T, et al.
Publicado: (2014)

Lung reaeration after surfactant instillation - caused by surfactant or caused by instillation?
por: Schultz, Marcus J
Publicado: (2010)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Pulmonary surfactant as a versatile biomaterial to fight COVID-19
por: Herman, Lore, et al.
Publicado: (2022)

Exogenous Pulmonary Surfactant as a Vehicle for Antimicrobials: Assessment of Surfactant-Antibacterial Interactions In Vitro
por: Birkun, Alexei
Publicado: (2014)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia
por: Mirastschijski, Ursula, et al.
Publicado: (2020)

Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components
por: Li, Dan, et al.
Publicado: (2022)

Group A Streptococcus Meningitis in Adults, Denmark
por: Nielsen, Henrik, et al.
Publicado: (2023)

Surfactant therapy and extracorporeal life support
por: Plötz, Frans B
Publicado: (2006)

Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19
por: Sinnberg, Tobias, et al.
Publicado: (2022)

Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
por: Busani, Stefano, et al.
Publicado: (2020)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

SURFACTANTS VERSUS COVID-19
por: Edser, Caroline
Publicado: (2020)

Pulmonary Surfactant: Biology and Therapy
por: Willson, Douglas F., et al.
Publicado: (2008)

Alveolar Epithelium and Pulmonary Surfactant
por: Mason, Robert J., et al.
Publicado: (2016)

Digital Tomosynthesis and COVID-19: An improvement in the assessment of pulmonary opacities()
por: Calvo, Inmaculada, et al.
Publicado: (2020)

Spatial analysis of photoplethysmography in cutaneous squamous cell carcinoma
por: Rasmussen, Simon Mylius, et al.
Publicado: (2022)

The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development
por: Scott, J Elliott
Publicado: (2004)

The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development
por: Scott, J Elliott
Publicado: (2004)

Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
por: Dushianthan, Ahilanandan, et al.
Publicado: (2020)

The demonstration of pulmonary surfactant by electron microscopy.
por: Meban, C.
Publicado: (1974)

The Accelerated Late Adsorption of Pulmonary Surfactant
por: Loney, Ryan W., et al.
Publicado: (2011)

Lung surfactant in subacute pulmonary disease
por: Devendra, Gehan, et al.
Publicado: (2002)

Lung surfactant alterations in pulmonary thromboembolism
por: Calkovska, A, et al.
Publicado: (2009)

The effect of surfactant on clinical outcome of patients with COVID-19 under mechanical ventilation: A structured summary of a study protocol for a randomised controlled trial
por: Dabbagh, Ali, et al.
Publicado: (2020)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
por: Kumar, Pradeep
Publicado: (2020)

Surfactant-free syntheses and pair distribution function analysis of osmium nanoparticles
por: Juelsholt, Mikkel, et al.
Publicado: (2022)

Applying logic to pulmonary artery catheter use
por: Kunig, Horst E, et al.
Publicado: (2008)

Photoplethysmography for demarcation of cutaneous squamous cell carcinoma
por: Rasmussen, Simon Mylius, et al.
Publicado: (2021)

Author Correction: Photoplethysmography for demarcation of cutaneous squamous cell carcinoma
por: Rasmussen, Simon Mylius, et al.
Publicado: (2022)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o78lce0br8vnpdo3aouaubdp4k